diisopropylamine dichloroacetate has been researched along with pyruvic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ANTONIOLI, G; MANZOLI, U; MASONI, A; RIPA, R; RUPERTI, A; TOMASI, AM | 1 |
Chida, J; Hanawa, M; Indalao, IL; Kido, H; Yamamoto, Y; Yamane, K | 1 |
2 other study(ies) available for diisopropylamine dichloroacetate and pyruvic acid
Article | Year |
---|---|
[DIISOPROPYLAMMONIUM DICHLOROETHANOATE IN PERIPHERAL VASCULAR DISEASE. EXPERIMENTAL STUDY OF THE CHANGES IN BLOOD SUGAR, PYRUVIC ACID AND LACTIC ACID].
Topics: Acetates; Ammonium Compounds; Arteriosclerosis Obliterans; Blood Chemical Analysis; Blood Glucose; Humans; Lactates; Lactic Acid; Peripheral Vascular Diseases; Pharmacology; Pyruvates; Pyruvic Acid; Quaternary Ammonium Compounds; Vascular Diseases | 1963 |
Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza.
Topics: Animals; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Influenza A Virus, H1N1 Subtype; Lipid Metabolism; Metabolic Diseases; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Orthomyxoviridae Infections; Oxidation-Reduction; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Pyruvic Acid; Quaternary Ammonium Compounds; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |